'Surprised and Disappointed': All Independent Board Members of 23andMe Resign, Leaving Only the CEO
Days after proposing to settle a data breach lawsuit for $30 million, 18-year-old genetic testing company 23andMe now faces another public hurdle: Seven independent directors of its board resigned on Tuesday through a pointed letter addressed to CEO Anne Wojcicki,